Cosmetic Grade GSH L-glutathione Skin Whitening Powder 70-18-8 Glutathione
Contact Person : Jane Jiang
Phone Number : 86-13572180216
WhatsApp : +8613572180216
|Minimum Order Quantity :||1kg||Price :||$24/kg~$100/kg|
|Packaging Details :||1kg: Sealed aluminum foil bags/25kg Paper Drum||Delivery Time :||3 Days|
|Payment Terms :||L/C, Western Union, MoneyGram, T/T||Supply Ability :||10Ton/Month|
|Place of Origin:||China||Brand Name:||HongdaPharma|
|Product Name:||Stephania Japonica Extract||Appearance:||Powder|
|Shelf Life:||2 Year||Particle Size:||80 Mesh|
|Latin Name:||Stephania Japonica|
Pure Natural Stephania Japonica Extract Cepharanthin 98% HPLC
|Product name:||Stephania Japonica Extract Cepharanthin 98%|
|Latin name:||Stephania Japonica|
|Color:||White Fine Powder|
|Particle Size:||100% pass 80 mesh|
|Loss on drying:||≤5.00%|
|Acid insoluble Ash:||≤5.0%|
|Heavy metals(as Pb):||≤10ppm|
|Total microbacterial count:||NMT10000cfu/g|
|Total Yeast & Mold:||NMT1000cfu/g|
Cepharanthin is extracted from the roots of endemic plant in Yunnan provence, Stephania japonica (Thunb.) Miers.. Cepharanthine can increase the number of peripheral blood leukocytes and promote bone marrow tissue hyperplasia, being mainly used to cure leukocytes decreasing and lacking caused by cancer chemotherapy and other factors. Now it is used in the treatment of thrombocytopenic purpura. It is convenient to dose for inhibition of pulmonary fibrosis without significant adverse reactions.
1. Cepharanthin can is used for promoting bone marrow tissue hyperplasia
2. Cepharanthin can is used for treating leukocytes decrease and lack caused by cancer chemotherapy and other factors
3. Cepharanthin can is used for treating thrombocytopenic purpura
4. Cepharanthin can is used for inhibiting pulmonary fibrosis without significant adverse reactions
What is Cepharanthine?
Cepharanthine, a leukocyte proliferation drug, can promote the proliferation of bone marrow tissue, thereby increasing white blood cells. with stem leukopenia. It can increase leukocytes in peripheral blood. Animal experiments have found that it can significantly prevent leukopenia caused by mitomycin, but does not inhibit the anticancer effect of mitomycin. Its mechanism of action is to promote the proliferation of bone marrow tissue, thereby producing the effect of increasing white blood cells. For agranulocytosis caused by tumor chemotherapy, radiotherapy and leukopenia caused by other reasons.
On May 10, 2022, a new drug for the treatment of COVID-19 discovered by Chinese scientists was granted a national invention patent. The patent specification shows that 10uM (micromol/L) of fenugreek can inhibit the replication of coronavirus by a factor of
15393 times. It can be understood that a very small amount of fenugreek can suppress the amplification and spread of the new coronavirus, and the drug's ability to inhibit the new coronavirus ranks high among all the new coronavirus inhibitors discovered by humans.